Primary navigation

    Emsam

    Drug - Emsam (transdermal selegiline) Delivering 6 mg in 24 hours, 9 mg in 24 hours, or 12 mg in 24 hours

    July 2006

    Therapeutic area - Depression

    Criteria

    • Emsam is being used for Major Depressive Disorder AND
    • Patient has failed on at least three other antidepressants due to ineffectiveness or intolerance AND
    • Patient will not concurrently be taking an SSRI, SNRI, tricyclic antidepressant (TCA), Wellbutrin (bupropion), Buspar (buspirone), meperidine, other MAO I’s, or carbamazepine. These drugs are contraindicated for use with Emsam

    Brand and generic names of SSRIs and SNRIs

    SSRIs and combination drugs
    Celexa (citalopram)
    Fluvoxamine
    Lexapro (escitalopram)
    Paxil (paroxetine)
    Prozac (fluoxetine)
    Symbyax (olanzapine/fluoxetine)
    Zoloft (sertraline)

    SNRI and others
    Cymbalta (duloxetine)
    Effexor (venlafaxine)
    Wellbutrin (bupropion)
    Buspar (buspirone)
    trazadone 

    Questions?

    MHCP Provider Call Center 651-431-2700 or 800-366-5411

    back to top